ARCHIVES

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991

Managed Care: Cancer Panel Finds Need “Critical” For Cost, Outcomes Data

September 13, 1996

In Brief: NCI To Go Along With NCAB on Keeping Clinical Education Program Alive; Cal Baldwin Retires

February 28, 1986

U.S. Tobacco Program Loses $505 il. In Loan Principle, Report Finds

January 12, 1990

Joint NCI/FDA Program approved; ‘May Solve Our Differences’

December 15, 1989

Cancer Program Progress Detailed

March 5, 1976